Pyxis Oncology, Inc. (PYXS) Revenue Growth
Pyxis Oncology, Inc. (PYXS) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2022-12-31 | N/A |
| 2023-12-31 | N/A |
| 2024-12-31 | 973.87% |
| 2025-12-31 | -13.84% |
How PYXS compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| NTLA | Intellia Therapeutics Inc. | 16.92% |
| VERU | Veru Inc. | 3.62% |
| BNTC | Benitec Biopharma Inc. | 2.74% |
| EYPT | EyePoint Pharmaceuticals Inc. | -27.50% |
| VYGR | Voyager Therapeutics Inc. | -49.53% |
These are five companies in the same sector as PYXS with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Pyxis Oncology, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("PYXS", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | PYXS | $3.89 | +9.12% | 2.23M |
| 3 | ||||
| 4 | ||||
| 5 |